Essential Biotechnology –
New Treatment for Hard to Treat Cancer
Jayson Kurfis
A protein, CRR9, serves as a nexus for tumor cell survival. It’s located on the cell surface, making it an accessible drug target. By developing antibodies to the CRR9 protein, Essential Biotechnology has devised a method to kill therapy-resistant tumors. Continue reading